Endometrial Cancer

This online course is a highlight from the 2021 live virtual symposium which was hosted by the Miami Cancer Institute. The symposium brought together a distinguished faculty to focus on the medical management of common and important challenges facing health-care professionals who care for women with cancer.  

Learn more about the Womens’ Cancer Symposium here.

Surgical Management of High-risk Endometrial Cancer: Should Sentinel Lymph Node be the Standard

In this course, Dr. Ginger Gardner of Memorial Sloan Kettering Cancer Center examines the benefits of sentinel lymph mapping for endometrial cancer. She discusses the technique and highlights the studies about detection and outcome. 

Learning Objective:
  • Evaluate the effectiveness of sentinel lymph node resection in the management of high-risk endometrial cancer.

Immunotherapy in Management of Endometrial Cancer

In this course, Dr. Shannon N. Westin of MD Anderson Cancer Center examines the utility of immunotherapy in the manage of endometrial cancer. 

Learning Objectives:
  • Review existing data to support use of immunotherapy in endometrial cancer.
  • Discuss ongoing trials including immunotherapy for the care of women with endometrial cancer.
  • Apply relevant testing strategies to guide choice of immunotherapy in endometrial cancer.
  • Discuss adverse event management of immunotherapy.

Target Audience

Breast Surgeons, General Surgeons, Reconstructive Surgeons, Obstetricians and Gynecologists, Oncologists, Medical Oncologists, Physiatrist, Radiation Oncologists, Pathologists, Geneticists, Radiologists, General Practitioners, Nurse Practitioners and all other interested healthcare professionals.

Additional information
  • Frumovitz, M., Plante, M., Lee, P. S., Sandadi, S., Lilja, J. F., Escobar, P. F., ... & Abu-Rustum, N. R. (2018). Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. The Lancet Oncology, 19(10), 1394-1403.
  • Sokol, E. S., Pavlick, D., Khiabanian, H., Frampton, G. M., Ross, J. S., Gregg, J. P., ... & Chung, J. H. (2020). Pan-cancer analysis of BRCA1 and BRCA2 genomic alterations and their association with genomic instability as measured by genome-wide loss of heterozygosity. JCO precision oncology, 4, 442-465.
  • Marabelle, A., Le, D. T., Ascierto, P. A., Di Giacomo, A. M., De Jesus-Acosta, A., Delord, J. P., ... & Diaz Jr, L. A. (2020). Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability/mismatch repair–deficient cancer: Results from the phase II KEYNOTE-158 study. Journal of Clinical Oncology, 38(1), 1-10.
Course Summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 General certificate of attendance
  • 1.00 Nurse Practitioners
Course opens: 
Course expires: 

Ginger J. Gardner, M.D., FACOG

Section, Ovarian Cancer Surgery
Physician Lead, Gynecology Disease Management Team Alliance
Vice Chair of Hospital Operations, Department of Surgery
Memorial Sloan Kettering Cancer Center
New York, New York

Shannon N. Westin, M.D., MPH
Associate Professor
Director, Early Drug Development and Phase 1 Trials
Department of Gynecologic Oncology and Reproductive Medicine
UT MD Anderson Cancer Center, 
Houston, Texas

John P. Diaz, M.D., FACOG

Director of Gynecologic Minimally Invasive Surgery 
Baptist Health South Florida
Lead Physician Clinical Research 
Gynecologic Oncology Clinical Trials
Miami Cancer Institute 

Gladys L. Giron, M.D., FACS 
Breast Surgical Oncology 
Cancer Liaison Physician 
Miami Cancer Institute 

Nicholas C. Lambrou, M.D., FACOG
Chief of Gynecologic Oncology, Miami Cancer Institute
Director of Robotic Surgery, Baptist Health South Florida
Associate Professor, Herbert Wertheim College of Medicine
Florida International University 

Starr K. Mautner, M.D., FACS
Breast Surgical Oncology
Cancer Liaison Physician 
Miami Cancer Institute

Ginger J. Gardner, M.D., FACOG, faculty for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and will not include discussion of off-label or unapproved product usage.

Shannon N. Westin, M.D., MPH, faculty for this educational activity, has indicated that she receives grant/research support from AstraZeneca, Clovis Oncology, Roche/Genentech, GSK/Tesaro, Novartis, Bayer, ArQule, Bio-Path, Cotinga Pharmaceuticals. She is also a consultant for Merck, Pfizer, Eisai, Zentalis, Agenus, and Circulogene and has indicated that the presentation or discussion will include off-label or unapproved product usage.

Symposium Directors

John P. Diaz, M.D., FACOG, has indicated that he is a member of the speakers’ bureau for AstraZeneca and Merck. 
Gladys L. Giron, M.D., FACS, has disclosed that her spouse is a consultant for Stryker.
Nicholas C. Lambrou, M.D., FACOG, has indicated that he is a consultant for Intuitive, Ethicon and Johnson & Johnson. 
Starr K. Mautner, M.D., FACS, conference director of this educational activity, has no relevant financial relationship to disclose with ineligible companies.*

All of the relevant financial relationships listed for these individuals have been mitigated.

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*. 

*Ineligible companies -- Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 General certificate of attendance
  • 1.00 Nurse Practitioners
Please login or register for a Baptist Health CME account to take this course.

Required Hardware/Software

PC/Mac Users
PC/Mac Users

This site is supported on the most recent stable releases of the following browsers:

Click Here to Download Google Chrome
Google Chrome
Microsoft Edge
Microsoft Edge
Moxilla Firefox
Mozilla Firefox
Internet Explorer

Attention: Internet Explorer Users
This site offers limited support for Internet Explorer 11 (IE11). When using IE11, you will be prompted to download course videos instead of viewing them in the browser. After the course video downloads, the recordings will play.

Mobile Users
Mobile Users

This site is supported on the following mobile devices:

  • Apple iOS mobile devices running iOS 10 or later
  • Android mobile devices running Android 4.4 or later, with the latest release of Google Chrome or Mozilla Firefox
Technical Support
Technical Support

If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.